Lilly Faces Black Market Issues for Obesity Drug Pre-Launch | Retatrutide News

Eli Lilly is dealing with a black market for its obesity drug Retatrutide before its launch. This issue highlights the drug's high demand and the need f...
Market News · October 12, 2026